Interpreting Lab results

Electrolytes

Creatinine

  • levels can be elevated due to non-renal failure causes
    • increased ingestion: big meat eaters, protein supplements
    • assay interference: DKA, fasting, hyper-lipidaemia, haemolysis and drugs eg. cephalosporins, barbiturates and some chemoRx
    • reduced tubular secretion: trimethoprim, H2 antagonists

Kidney failure staging

Stage eGFR
ml/min/1.73m2BSA
description ACR (AlbCreat mg/mmol Ratio) is used to calculate the ‘A stage’ of CKD
1 =90 Normal A1 – <3
A2 – 3-30
A3 – >30
2 60-89 Mild
3a 45-59 Mild Moderate
3b 30-44 Moderate
4 15-29 Severe
5 <15 Kidney Failure

Hypercalcaemia

  • Primary hyperparathyroidism and malignancy are the two most common causes of increased serum calcium levels. If PTH levels are detectable, generally speaking the cause of hyper Ca++ is primary hyperparathyroidism
  • other causes include sarcoidosis, thyrotoxicosis
  • severe hypercalcaemia (>3.5 mmol/L) requires emergency management
  • can cause:
    • nephrogenic diabetes insipidus
    • abdo pain - constipation, ileus, pancreatitis
    • fatigue and even coma, Muscle weakness
  • Emergency Mx - IV saline, IV bisphosphonate if no success.
    • Other agents: calcitonin (100U SC per 6-8/24 or ≤10U/kg IV over 6/24 in emergency), dialysis, mithramycin and also anti-resorptive agent denosumab

Hypocalcaemia

  • acquired or hereditary. Acquired causes include:
    • hypoparathyroidism
    • liver disease
    • kidney disease
    • pancreatitis, COVID-19
    • hyperphosphataemia, hypomagnesaemia, vit D deficiency
    • diet, medication, and surgery
Management
  • Severe (ionized Ca++ <1 mmol/L) - 10-20ml of 10% calcium gluconate over 10mins and repeated per hour until tetany, seizure or laryngospasm resolves
  • Without seizure or tetany: 10ml 10% over 1/24
  • 10ml of 10% solution (100mg/ml) = 1g = 2.2mmol

Hypochloraemia

  • recurrent vomiting, gastric acid loss
  • diuretic-induced alkalosis (loop or thiazide diuretics)
  • posthypercapnic metabolic alkalosis.
  • CLD, cystic fibrosis, and laxative abuse are also potential causes.

Hyperkalaemia

  • acute or chronic AKI/CKD
  • DKA
  • drug causes
Mild 5.5-5.9mmol/L
moderate 6.0-6.5mmol/L
severe >6.5mmol/L

ECG changes in rough order of appearance:

  • Peaked T waves with a shortened QT interval
  • prolonged PR and QRS complex
  • disappearance of p wave
  • widening of QRS eventually progressing to a sine wave before asystole
Management
Stabilising the cardiac membrane with calcium ions. 10mL of 10% Ca++ gluconate (=2.2mmol) or chloride (6.8mmol)
caution: bradycardia and arrhythmias
Driving extracellular potassium into the cells 1. 10U actrapid, 50mL of 50% glucose
2. Neb Salbutamol 20mg or IV 0.5mg
3. HCO3- infusion - 1mmol/kg. ..if acidotic. Not useful on its own. Adjunct to #1&2
Removing excess potassium from the body 1. binders - Sodium zirconium cyclosilicate (Lokelma) 10g tds intially, action onset 1/24, Patiroma calcium 8.4g OD onset 4-7/24, Sodium polystyrene sulfonate (Resonium) 15g tds.
2. Dialysis
3. diuretics - mannitol, furosemide - theoretical but no trials to support

rqia guidelines for Hyperkalaemia 2021

Hypokalaemia

  • Increased GI losses
    • vomiting & diarrhoeal causes
    • bowel preps
  • tumour related - intestinal adenomas
  • Renal losses
    • Diuretics, amphotericin
    • hypomagnesaemia
    • renal tubular acidosis
    • other salt wasting nephropathies
  • Skin losses - sweating, CF, other skin conditions including burns

*Dialysis and other transfusion related conditions

  • Chronic alcoholism
  • hyperaldosteronism
  • associated with DKA

Requires treatment when severe - eg <2.5mmol/L or symptomatic

  • severe muscle weakness, paralysis
  • DKA
  • cardiac arrhythmias

Hypernatraemia

  • usually in elderly with mental or physical disability exacerbated by acute infection
  • as a result of impaired thirst or access to adequate water or increased losses
  • water losses - diuretics, osmotic diuresis (eg hyperglycaemia), acute tubular necrosis, GI losses and sweating

Hyponatraemia

  • represents water excess
  • often related to loop diuretics but also associated with other disease processes which have been recognised to initiate SIADH

Hypophosphataemia

  • redistribution - associated with major surgery fluid shifts, insulin/glucagon/adrenaline use, respiratory alkalosis
    • beware esp in Rx of hyperglycaemia, DKA (osmotic losses + redistribution with insulin)
  • decreased absorption - malnutrition, alcohol Xs, anorexia
  • increased renal loss - associated with diuretics
  • renal replacement therapies - loss in effluent with large fluid shifts
  • Clinical - muscle weakness, CNS changes, poor WCC function reducing resistance to infection, arrhythmias
  • Treatment - depends on level
    • <0.64mmol/l & asymptomatic - preferably enteral replacement (Phosphate Sandoz tablets contain 500mg elemental phosphorous - 4-6 tablets daily for adults, 2-3 for kids)
    • <0.32mmol/l or symptomatic - parenteral replacement

CRP

C-reactive protein - increases with age and BMI

  • synthesised in liver in response to inflammatory stimuli, usually peaking in 2/7
  • both pro and anti-inflammatory actions
  • exact mechanism of actin unknown but triggers complement pathway and others
  • also produced in endothelium, smooth M and adipose tissue
  • t1/2 = 20/24
  • raised in response to any inflammatory stimulus - infection (viral, TB, fungal etc), trauma, auto-immune diseases (Crohn disease, rheumatoid arthritis, juvenile idiopathic arthritis, vasculitis, autoimmune hepatitis), necrosis, ischaemia, malignancy etc
  • high sensitivity CRP (hs-CRP) useful in high risk coronary disease

Lactate

Lactic acidosis - Raised Lactate with pH≤7.35
hyperlactaemia - lactate >2 regardless of pH
elevated Lactate levels usually result from tissue hypo-perfusion or hypoxia.
Consider:
•shock, sepsis, anaemia
•malignancy, liver disease, DKA
•drugs - ß agonists, Metformin, paracetamol, cocaine

Lipase

Lipase is found in most parts of the GI tract but has also has been found in liver, heart, lungs and leukocytes

  • acute pancreatitis usually associated with 2-3x rise in lipase
  • less significant rise in lipase associated with many illnesses
  • more specific than amylase for pancreatitis
  • significant increases in lipase (>3x upper limit) can be seen with:
    • reduced clearance of lipase caused by renal impairment or macrolipase formation
    • other hepatobiliary, gastroduodenal, intestinal and neoplastic causes
    • critical illness, including neurosurgical pathology
    • alternative pancreatic diagnoses, such as non-pathological pancreatic hyperenzymaemia
    • miscellaneous causes such as diabetes, drugs and infections. (esp. Narcotics, thiazide diuretics, oral contraceptives, adrenocorticotropic hormone, cholinergics but many others as well have been associated with rise)
    • Multi trauma without head injury can also cause 3x rise in lipase

non pancreatic causes of raised lipase

βHCG

  • considerable variation but 50% women will have values as below within 3/7 of value shown
  • tend to plateau and begin to decline around d60 (ie. ~9/40)

http://pathology.royalberkshire.nhs.uk/HCGrange.php

HCG day post LMP
42 24
53 25
67 26
85 27
113 28
150 29
200 30
267 31
350 32
450 33
592 34
784 35
1084 36
1418 37
1918 38
2586 39
3587 40
5171 41
6840 42
9175 43
11677 44
15014 45
19184 46
23355 47
28359 48
33364 49
38369 50
42539 51
46710 52
51714 53
56719 54
61723 55
66728 56
71733 57
75903 58
80074 59
84244 60

Pro BNP

Procalcitonin

  • Practically all PCT formed in thyroid C cells is converted to calcitonin so that no PCT is released into the circulation. Hence, the PCT level in healthy subjects is very low (0.05 ng/mL)
  • inflammatory release of PCT is independent. During inflammation, PCT is produced mainly by two alternative mechanisms; direct pathway induced by lipopolysaccharide (LPS) or other toxic metabolite from microbes and indirect pathway induced by various inflammatory mediators like IL-6, TNF-a, etc
  • PCT is generally elevated by bacterial infection but not viral
  • not usually raised with PE and therefore may be useful in differentiating pneumonia and PE particularly when associated with fever

Troponin

  • patients with a 5 mL/min/1.73 m2 lower mean eGFR had 13% higher levels of mean hs‐cTnT.
  • patients with pre-existing CHF had a 34% higher level of hs‐cTnT, history of hypertension (34%), myocardial infarct (33%), angina pectoris (31%), atrial fibrillation (26%), of male sex (24%), diabetes mellitus (24%), and patients with lower hemoglobin (4% per 10 g/L).
  • reason for raised Trop is unclear in CKD - may be related to reduced clearance although small molecules are able to pass through glomerular membrane. May be due to chronic stress assoc with CKD

Assoc b/w Troponin and renal function - AHA 2019

troponin is known to rise post neurological insult eg. SAH, but is also associated with seizures ESocJ seizures

VBG

Venous Blood Gas

how it compares with ABG art venous
pH • good correlation 7.35-7.45 7.31-7.41
pO2 • poor correlation
• useful in tracking change
10.6-13.3 4.0-5.3
pCO2 • good correlation usually
• poor in severe shock and worsens with higher values
4.7-6.0 5.5-6.8
HCO3 • good correlation 22-28 23-29
Lactate • good correlation at 1st but worsens as levels increase
Base Excess • good correlation

Full Blood Exam

Hb
WCC aside from infection, acute rise in trauma, pregnancy
PMN
Platelets thrombocytopaenia, thrombocytosis

Thrombocytosis

Thrombocythemia - high platelet count that is not caused by another health condition. AKA primary or essential thrombocythemia.
Thrombocytosis - high platelet count secondary to other disease or condition. AKA secondary or reactive thrombocytosis. More common than thrombocythemia.

Thrombocytosis

  • Anemia: Iron-deficiency anemia and hemolytic anemia
  • Cancer - esp lung, gastrointestinal, breast, or ovarian cancer or lymphoma.Occasionally is first sign of cancer.
  • Splenectomy: stores platelets. Removing your spleen can raise your platelet count.
  • Inflammation/infections - eg. connective tissue disorders, inflammatory bowel disease, and tuberculosis

Erythrocyte Sedimentation Rate (ESR)

ESR review 2021

  • The Westergren method measures the distance (in millimeters) at which red blood cells in anticoagulated whole blood fall to the bottom of a standardized, upright, elongated tube over one hour due to the influence of gravity
  • useful, but not specific, to monitor many inflammatory disease processes
  • typically higher in females, and increases with age
  • Polycythaemia, spherocytosis and sickle cell may lower ESR
  • extreme elevation seen in: infection, collagen vascular disease, metastatic disease

Clotting

PT APTT
prolonged normal Factor VII deficiency
Mild vitamin K deficiency
Liver disease
Warfarin (can prolong both in higher doses
DIC
normal prolonged Deficiency of factor VIII, IX, or XI
Deficiency of factor XII, prekallikrein, or HMW kininogen (not associated with a bleeding diathesis)
von Willebrand disease (variable)
Heparin, dabigatran, argatroban, direct factor Xa inhibitors (variable)
Acquired inhibitor of factor VIII, IX, XI, or XII
Acquired von Willebrand syndrome
Lupus anticoagulant (more likely to be associated with thrombosis than bleeding)
prolonged prolonged Deficiency of prothrombin, fibrinogen, factor V, or factor X
Combined factor deficiencies
Liver disease
DIC
Severe vitamin K deficiency
Anticoagulants (supratherapeutic doses of many anticoagulants, combined heparin and warfarin, direct thrombin inhibitors, anticoagulant rodenticide poisoning)
Acquired inhibitor of prothrombin, fibrinogen, factor V, or factor X
Amyloidosis-associated factor X deficiency
Warfarin typically prolongs the PT alone, but at high levels warfarin can prolong both tests.
Heparin typically prolongs the aPTT alone (because PT reagents contain heparin-binding agents that block heparin effect), but at high levels heparin can prolong both tests.
Direct thrombin inhibitors (argatroban, dabigatran) typically prolong both tests, but at low levels dabigatran may not prolong the PT.
Direct factor Xa inhibitors (apixaban, edoxaban, rivaroxaban) can prolong the PT and aPTT, although these effects are variable.
UpToDate
INR Major bleeding in patients on warfarin (in combination with dried prothrombin complex or fresh frozen plasma) for phytomenadione
By slow intravenous injection - Adult
5 mg for 1 dose, stop warfarin treatment.
INR > 8.0 with minor bleeding in patients on warfarin for phytomenadione, by slow IV - Adult
1–3 mg, stop warfarin treatment, dose may be repeated if INR still too high after 24 hours, restart warfarin treatment when INR <5.
INR > 8.0 with no bleeding in patients on warfarin for phytomenadione by mouth - Adult
1–5 mg, IV preparation to be used orally, stop warfarin treatment, repeat dose if INR still too high after 24 hours, restart warfarin treatment when INR <5.
INR 5.0–8.0 with minor bleeding in patients on warfarin for phytomenadione by slow IV injection - Adult
1–3 mg, stop warfarin treatment, restart warfarin treatment when INR <5.

d-Dimer

  • raised d-Dimer needs to be interpreted in context and VTE can be found despite a -ve d-Dimer result eg. small or matured clots or in patients with deranged fibrinolysis eg Factor XIII def.
  • Often raised in conditions other than 'pure' VTE:
    • 60% older patients have d-Dimer value higher than classical cutoff. An age related formula is useful for patients >50y: Age (years) x 10 µg/L
    • trauma
    • upper GI haemorrhage and liver disease
    • stroke
    • ACS, AF, lipaemia
    • consumptive coagulopathy - DIC, VICC (venom induced consumptive coagulopathy)
    • later stages of pregnancy & pre-eclampsia
    • inflammatory disorders, malignancy, sickle cell disease
    • often raised in elderly and , cigarette smokers, Afro-Americans, post-op
    • Afro-Caribbean patients, especially women, typically have much higher d-Dimer levels. However, also associated with other co-morbidities and poor outcomes

J of thrombosis & haemostasis - dDimer and ethnicity
J of Gerontology - dDimer and age, functional status etc

d-Dimer in PREGNANCY: For pregnant women, the following D-Dimer reference value ranges are proposed: dDimer in pregnancy

  • 1st trimester: 167-721 ng/mL
  • 2nd trimester: 298-1653 ng/mL
  • 3rd trimester: 483-2256 ng/mL

fibrinogen in pregnancy:

  • 1st trimester: 2.64-6.56 g/L
  • 2nd trimester: 3.40-8.53 g/L
  • 3rd trimester: 3.63-9.14 g/L.

d-Dimer in LIVER DISEASE:

  • Infection: typically raised with CAP according to severity. Using Pneumonia Severity Score (PSI):
dDimer varies with PSI
Group 1 ~190
Group 2 ~320
Group 3 ~470
Group 4 ~660
Group 5 ~1230
  • 'rule out' for imaging etc still requires using Wells or other clinical criteria

(View Cascade)close

Liver function tests

AST • raised in proportion to cellular damage and especially early stage of necrosis
• found in cardiac and skeletal M, kidney, brain, pancreas and red cells and therefore ??? in skeletal M trauma and other Muscle disorders, MI, hepatitis etc
ALT • levels not related to degree of liver necrosis and not useful in prognosis
• more specific than AST for liver damage
• higher levels seen with chronic hepatitis, cholestasis, CCF, infectious mononucleosis, various drugs eg paracetamol, phenothiazines, barbiturates, morphine, tetracyclines
• isolated elevated ALT - consider rechecking in >6/12. If remains high - then Ix for hepatocellular disease
• remember that 'normal' range is just that - Bell curve means that 2.5% pop will be outside 'normal' range
AST:ALT <1 • viral hepatitis
• severe toxic hepatitis
• ischaemic hepatitis
AST:ALT >2.5 • classic alcoholic liver disease with acute hepatocellular injury
• active cirrhosis
ALP • primarily biliary stasis/obstruction and malignancy
• also a marker of bone turnover and therefore seen with bony disorders & metastases
• normally high in late pregnancy
dGT • sensitive to alcohol ingestion and especially with biliary obstruction
• also raised in pancreatitis, brain tumours, renal and prostatic disease and post MI
LDH • found in most tissues
• especially raised in CCF, PE's and infarction, anaemias, hepatitis
StatPearls 2021 LDH biochem

Summary of enzyme patterns in Liver Disease

ALP AST ALT dGT other
Cholestasis ↑↑ ↑↑ AST:ALT<1.5 suggests extrahepatic, >1.5 suggests intrahepatic
Prim Biliary Cirrhosis ↑↑↑ ↑/N ↑/N ↑↑ raised AST:ALT suggests cirrhosis
Prim sclerosing cholangitis ↑↑ ↑/N ↑/N ↑↑ AST:ALT>1 may suggest cirrhosis
>1.12 suggests risk of varices
Alcoholic Liver Disease ↑/N ↑↑ AST:ALT>2
NAFLD/NASH ↑/N AST:ALT<1 unless cirrhosis
Wilsons disease ↑↑ ↑↑ ALP:bili<4, AST:ALT>2.2
Hep B, C ↑↑/N ↑↑/N AST:ALT>1 suggests cirrhosis
AST:platelets>1.5 suggests moderate fibrosis
enzymes may all be N
Autoimmune Hepatitis ↑↑ ↑↑ persistently high transaminases suggests poor prognosis
Ischaemic/shock injury
Toxic injury
↑↑↑ ↑↑↑

vit B12

Elevated B12 in clinical practice - review 2013
paradoxically accompanied by signs of deficiency, - a functional deficiency linked to qualitative abnormalities,eg. defects in tissue uptake and action of vitamin B12 high levels not infrequently associated with solid tumours:

  • myeloproliferative blood disorders
  • hepatocellular carcinoma (HCC) and secondary liver tumours
  • breast cancer, colon cancer, cancer of the stomach and pancreatic tumours.

References include: